Favipiravir CAS 259793-96-9 T-705 Kuchena ≥99.0% (HPLC) COVID-19 API Factory High Quality
Mugadziri ane Kuchena Kwepamusoro uye Hwakagadzikana Hunhu
Commerce Supply Favipiravir uye Inoenderana Nepakati:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Chemical Name | Favipiravir |
Mashoko anoreva zvakafanana | T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxemide |
Nhamba yeCAS | 259793-96-9 |
Nhamba yeCAT | RF-API18 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram |
Molecular Formula | C5H4FN3O2 |
Molecular Weight | 157.1 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kusvika kuOff-White Powder |
Kuzivikanwa 1H-NMR | Zvinoenderana neyakarongwa chimiro |
Kuzivikanwa HPLC | Nguva yekuchengeta yepamusoro-soro mugadziriro yemuenzaniso inofanirwa kuenderana nenguva yekuchengeta yepamusoro-soro mureferensi gadziriro yegadziriro. |
Kuzivikanwa Misa | Mass Spectrum inoenderana neyakarongwa chimiro |
Melting Point | 188.0℃-193.0℃ |
Related Substances (Area Normalization) | Chero Kusachena Kumwechete: ≤0.10% (HPLC) |
Zvose Zvisina Kuchena: ≤1.0% (HPLC) | |
Kuchena / Analysis Method | ≥99.0% (HPLC) |
Kunyorova (KF) | ≤0.50% |
Residue paIgnition | ≤0.10% |
Heavy Metals | ≤20ppm |
Residue Solvents | |
Methanol | ≤3000ppm |
Isopropanol | ≤5000ppm |
n-Heptane | ≤5000ppm |
Ethanol | ≤5000ppm |
Test Standard | Enterprise Standard |
Usage | Active Pharmaceutical Ingredient (API);Kurapwa kweCOVID-19 |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard dhiramu, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
Favipiravir (T-705) (CAS 259793-96-9) ndeimwe yemakomisheni mashanu anokurudzirwa neWHO pakuongorora kurapwa kweCOVID-19.Favipiravir is selective inhibitor yeviral RNA-inotsamira RNA polymerase ine basa rinopesana neakawanda maRNA mavhairasi, furuwenza, West Nile virus, yellow fever virus, tsoka-uye-muromo chirwere hutachiona pamwe nemamwe maflaviviruses, arenaviruses, bunyaviruses uye alphaviruses.Favipiravir mushonga wekurwisa hutachiona wakafaranuka wakacheneswa neDrugs Controller General weIndia (DCGI) svondo rapfuura nekuda kwekushandiswa "kwechimbichimbi" pakati pevarwere veCovid-19.Favipiravir yakatanga kugadzirwa mukupera kwema1990s nekambani yakazotengwa nekambani yeJapan Fujifilm sechikamu cheshanduko yayo kubva kubhizinesi remifananidzo kuenda kuhutano.Mushure mekuyedzwa kurwisa huwandu hwehutachiona, mushonga uyu wakabvumidzwa muJapan muna 2014 kuti ushandiswe nechimbichimbi kurwisa denda refuruwenza kana kurapa mhando nyowani dzefuruwenza.